Two companies are expected to debut on the Nasdaq this week, each planning to command a nine-figure IPO.
BioNTech SE (NASDAQ:BNTX), a German biotechnology company developing individualized immunotherapies to treat cancer, plans to raise $251 million in its IPO. The company is set to offer 13.2 million shares at a price between $18 and $20 per share.
An IPO of that size would give the company a market cap of $4.45 billion and make it the third-largest development-stage biotech to list in the US, according to broker Renaissance Capital.
Founded in 2008, the company has a drug pipeline of more than 20 product candidates, seven of which have entered into eight clinical trials.
HBT Financial Inc (NASDAQ:HBT), a bank holding company based in Bloomington, Illinois, hopes to raise $149 million by offering 8.3 million shares at a price between $17 and $19 per share.
As of June 30, HBT had total assets of $3.2 billion. It had loans held for investment of $2.2 billion, total deposits of $2.8 billion and stockholders' equity of $340 million.
Its bank subsidiaries, Heartland Bank and Lincoln Bank, operate 64 branches in central and northeastern Illinois.
HBT Financial was formerly known as Heartland Bancorp.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel